Showing 3091-3100 of 5956 results for "".
- Ziemer USA Sponsors Visionary Leader Award at OWL Meetinghttps://modernod.com/news/ziemer-usa-sponsors-visionary-leader-award-at-owl-meeting/2479819/Ziemer USA has announced it is sponsoring the Visionary Leader award, presented at the OWL Signature Event and Awards Ceremony. The OWL (Ophthalmic World Leaders) Visionary Leader award honors an individual who has pa
- Eyevance Acquires Global Rights to Persistent Corneal Epithelial Defect Treatment Nexagonhttps://modernod.com/news/eyevance-acquires-global-rights-to-persistent-corneal-epithelial-defect-treatment-nexagon/2479822/Eyevance Pharmaceuticals announced a worldwide licensing agreement with OcuNexus Therapeutics for Nexagon, a 30-base antisense oligomer being developed for the orphan indication of persistent corneal epithelial defect (PED) nonresponsive to standard of care. Terms of the deal were not disc
- Visioneering Technologies Selects Corneal Lens Corporation NZ and Contact Lens Centre Australia to Distribute NaturalVue Brand Contact Lenses in ANZhttps://modernod.com/news/visioneering-technologies-selects-corneal-lens-corporation-nz-and-contact-lens-centre-australia-to-distribute-naturalvue-brand-contact-lenses-in-anz/2479825/Visioneering Technologies announced that it has signed an agreement with Corneal Lens Corporation (CLC) and its associated company Contact Lens Centre Australia (CLCA), making them authorized distributors of Visioneering’s NaturalVue (etafilcon A) Brand 1 Day Contact Lenses in New Zealand and Aus
- AAO: New Study Confirms Mediterranean Diet Prevents AMD Developmenthttps://modernod.com/news/aao-new-study-confirms-mediterranean-diet-prevents-a-leading-cause-of-blindness/2479827/Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration (AMD). A large
- PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceuticalhttps://modernod.com/news/peptidream-announces-drug-discovery-and-development-agreement-with-santen-pharmaceutical/2479839/PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company, announced that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based Santen Pharmaceuticals. Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform
- CooperVision Releases Four-Year Data on Landmark MiSight 1-Day Contact Lens Studyhttps://modernod.com/news/coopervision-releases-four-year-data-on-landmark-misight-1-day-contact-lens-study/2479840/New 4-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia in children, including those whose treatment begins later. CooperVision recently presented the multi-year study’s latest outcomes during the
- Hoya Launches 4-in-1 Multisert Preloaded Delivery System with Vivinex IOLhttps://modernod.com/news/hoya-launches-4-in-1-multisert-preloaded-delivery-system-with-vivinex-iol/2479847/Hoya Surgical Optics officially launched the new multiSert 4-in-1 preloaded delivery system with Vivinex IOL at the European Society of Cataract and Refractive Surgeons (ESCRS) in Vienna, Austria. “MultiSert is
- CooperVision Releases 4-Year Data on Landmark MiSight 1-Day Contact Lens Studyhttps://modernod.com/news/coopervision-releases-4-year-data-on-landmark-misight-1-day-contact-lens-study/2479874/New 4-year study data shows the the impact of a pioneering contact lens management approach to slowing the progression of myopia in children, including those whose treatment begins later, according to a CooperVision news release. CooperVision is presenting the multi-year study’s latest out
- LumiThera to Debut Valeda Light Delivery System at EURETINAhttps://modernod.com/news/lumithera-to-debut-valeda-light-delivery-system-at-euretina/2479887/LumiThera announced that it will debut the Valeda Light Delivery System for the treatment of dry AMD in the exhibition hall at the EURETINA meeting in Vienna. It will also host a symposium on photobiomodulation (PBM) technology entitled, “Photobiomodulation: An Innovative, Mitochondria-targ
- Alcon Introduces New AIR OPTIX Plus HydraGlyde Multifocal Contact Lenseshttps://modernod.com/news/alcon-introduces-new-air-optix-plus-hydraglyde-multifocal-contact-lenses/2479894/Alcon is expanding its multifocal portfolio with the launch of AIR OPTIX plus HydraGlyde multifocal contact lenses. As with Alcon’s other multifocal portfolio contact lens options – including DAILIES TOTAL1, DAILIES AquaComfort Plus, and AIR OPTIX AQUA – this latest innovation offers presbyopic p